Federal government agency

National Cancer Institute Grants

20 open National Cancer Institute grants accepting applications right now. Historical giving: 2,544 grants totaling $1.6B.

Want AI mission-fit scoring on National Cancer Institute opportunities? Start a free trial.

All-time tracked giving
$1.6B
2,544 grants
Median grant size
$419K
Max: $83M

Open National Cancer Institute grants

  • Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection

    Up to $4.9MDeadline: Jul 31, 2029open

    /Abstract Infection of Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), is estimated to account for 34,000 ne...

  • Conversational Agent to Improve Guideline Concordant Care for People with Cervical Cancer Screening Abnormalities

    Up to $3.3MDeadline: Jul 31, 2029open

    / ABSTRACT Cervical cancer is almost entirely preventable with appropriate screening and management of abnormal results, yet in the US, over 14,000 in...

  • Magnetic Resonance Fingerprinting of Glutamate Metabolism for Guiding Glioma Cancer Care

    Up to $3.2MDeadline: Jul 31, 2029open

    Glioblastoma (GBM) is the most common type of malignant primary brain tumor found in adults and is fatal in all cases with a median survival time of o...

  • Controllable solid tumor immunotherapy based on a wireless thermos-activator

    Up to $3.0MDeadline: Jul 31, 2029open

    Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking treatment for cancer, with the potential to elicit long-lasting immune responses. H...

  • Non-invasive etiology-adjusted precision liver cancer risk prediction

    Up to $2.9MDeadline: Jul 31, 2029open

    Hepatocellular carcinoma (HCC) is the major histological type of liver cancer, caused by viral (HBV, HCV) and metabolic (alcohol, metabolic dysfunctio...

  • Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification

    Up to $2.8MDeadline: Jul 30, 2029open

    Cyclophosphamide (CPA) and doxorubicin (DOX)-containing regimens are extensively utilized in treating various malignancies, including triple-negative ...

  • Supporting Informed Parental Decisions on HPV Vaccination through Safe and Personalized AI-Driven Conversations

    Up to $2.8MDeadline: Jul 31, 2029open

    This project aims to support informed decision making about Human Papillomavirus (HPV) vaccination among parents of adolescents in the United States t...

  • New methods to measure and interrupt metabolic fluxes in brain cancer

    Up to $2.8MDeadline: Jul 31, 2029open

    Glioblastomas (GBMs) are deadly incurable brain cancers that are treated with resection followed by radiation, which is often combined with chemothera...

  • Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging

    Up to $2.7MDeadline: Jul 31, 2030open

    Paclitaxel-induced peripheral neuropathy (PIPN) is a common painful treatment side effect that affects millions of cancer patients. Currently there ar...

  • Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines

    Up to $2.6MDeadline: Jul 31, 2029open

    Dendritic cells (DCs) are pivotal in mediating anti-tumor immunity, and an effective DC vaccine devoid of intolerable immune-related toxicity would be...

  • Fluorescence guided nerve sparing during colorectal cancer surgery using local application of a near infrared nerve fluorophore

    Up to $2.5MDeadline: Jul 31, 2029open

    Colorectal cancer (CRC) is the second leading cause of cancer death and is predicted to cause nearly 10% of cancer deaths worldwide in 2024. Rectal ca...

  • CP-CTNet Coordinating Center

    Up to $2.5MDeadline: Jul 31, 2031open

    /Abstract Cancer is the leading cause of morbidity and mortality in the US and in the world. One approach to reducing the risk and burden of cancer is...

  • Targeting Myeloid Metabolism to Reprogram the Tumor Microenvironment of Glioblastoma

    Up to $2.5MDeadline: Jul 31, 2029open

    IDH1R132H mutation is recognized as the most common initiating event for low-grade glioma and IDH1- mutant grade IV astrocytoma. Our recent study (Ste...

  • ROLE OF RNA SEQUESTRATION IN ACUTE MYELOID LEUKEMIA

    Up to $2.4MDeadline: Jul 31, 2029open

    Post-transcriptional mechanisms play crucial roles in maintenance of progenitor cell identity and have been implicated in cancer development, includin...

  • Convergent Epigenetic Control of Neuroendocrine Cancers

    Up to $2.4MDeadline: Mar 31, 2030open

    Summary (Overall) The overall goal of the Program “Convergent Epigenetic Control of Diverse Neuroendocrine Cancers” is to interrogate epigenetic and ...

  • The impact of dyadic processes on smoking and cigarette craving: An experimental investigation of romantic partners and smoking friends

    Up to $2.2MDeadline: Jul 31, 2029open

    Smoking is the leading preventable cause of cancer and mortality in the US, with Covid hitting smokers especially hard. Quitting is difficult (and smo...

  • FY25 TASK ORDER D - BASE: WO 126680 B539 EAST BASEMENT SWITCHBOARDREPLACEMENT. OPTION 1: 126680A B539 WEST ATTIC SWITCHBOARDREPLACEMENT

    Up to $2.0MDeadline: Mar 3, 2028open

    Base - The purpose of this project is to replace five aged switchboards in the East Basement of B539 with new code compliant switchboards. Additional ...

  • Principles of Speckle-Based Gene Regulation

    Up to $1.7MDeadline: Jul 31, 2028open

    The cell nucleus houses different types of non-DNA substructures, called nuclear bodies. Among these, nuclear speckles predominate. Speckles occupy ~1...

  • Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.

    Up to $1.7MDeadline: Jul 31, 2027open

    Summary This Direct to Phase II SBIR proposal aims to further develop and validate a deep learning radiomics biomarker for improved early response ass...

  • A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab

    Up to $1.5MDeadline: Jul 31, 2028open

    Metastatic microsatellite stable colorectal cancer (MSS-CRC) accounts for 80% of CRCs with a standard of care that provides a dismal 10% objective res...

Where National Cancer Institute grants go

Recent grant recipients are concentrated in these states. Funders sometimes fund outside their primary states for high-fit projects, so don't self-eliminate solely on geography — check each opportunity's stated eligibility.

CANYTXMAPANCMDILFLOH

What National Cancer Institute funds

Top program areas based on GrantMind's analysis of recent National Cancer Institute awards:

Cancer Research

How to apply for National Cancer Institute grants

Most National Cancer Institute applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.

Read: How to write a Letter of Inquiry that gets you invited to apply

Find every National Cancer Institute opportunity matched to your mission

Sign up free for AI mission-fit scoring across National Cancer Institute and 75,000+ other active funders. Find the opportunities that match what you do, qualify them in seconds, and draft proposals tuned to each funder's stated priorities.

Start 7-day free trial

Card required, not charged until day 8 · Cancel anytime